Drug Target Deconvolution | Structural Proteomics

Drug Target Deconvolution

Greater precision for more transformative drug discovery

Target identification and validation are key challenges in drug discovery. By applying Limited Proteolysis coupled with Mass Spectrometry (LiP-MS), our Drug Target Deconvolution service offers a unique way to help you optimize and de-risk your drug discovery journey.


    Unveiling the target of a small molecule compound is key to gaining deeper insight into its mechanism of action and potential toxicities.

    Limited Proteolysis Mass Spectrometry (LiP-MS) is a novel, label-free approach to identify on- and off-target binding effects throughout the proteome. LiP-MS is the only tool to probe protein structural alterations on a proteome scale with peptide-level resolution.

    The study report will provide you with ranked protein target candidates for rapid target deconvolution and streamlined target validation.

    Biognosys is the sole, exclusive provider of proteomics solutions based on the patented LiP-MS technology, developed in collaboration with the group of Prof. Paola Picotti at ETH Zurich.

    “The LiP technology is a very valuable tool to identify target and off-target of novel compounds whatever the organism and to support the process of target deconvolution in research. The interactions with Biognosys are very nice and fruitful. The team is engaged and responsive throughout the project.”

    Thomas Knobloch,
    Laboratory Manager, Bayer


    Filter By


    The results are presented and discussed with you in a seminar or webinar and delivered electronically in PDF and Excel formats.

    Executive Summary
    Materials and Methods
    (suitable for publication)
    Complete Data Matrix

    Dose response curves for LiP peptides from protein candidates

    Target Deconvolution Analysis

    a) Protein target candidates ranked by aggregate LiP score

    b) Compound affinity concentration for each protein candidate

    c) Mapping of regulated peptides of top 3 candidates on protein tertiary structures if available

    Sample types and depths

    Drug Target Deconvolution is applicable to complex biological matrices, including a wide variety of cell lines and organisms.


    Project management

    Biognosys is committed to providing the best possible results to our customers at the fastest possible project turnaround time.



    Access our knowledge base with relevant resources and guiding information.


      Close banner

      New: Drug Target Validation

      Reveal Binding Sites with Structural Proteomics

      New: Drug Target Validation

      Reveal Compound Binding Sites with Structural Proteomics

      Learn More